Equities

Odonate Inc

ODTC:PKL

Odonate Inc

Actions
  • Price (USD)17,100.00
  • Today's Change0.00 / 0.00%
  • Shares traded1.00
  • 1 Year change+3.64%
  • Beta0.1531
Data delayed at least 15 minutes, as of Jun 26 2024 15:19 BST.
More ▼
Improved Notifications for Markets Data Alerts
Improved Notifications for Markets Data Alerts
Want push notifications sent directly to your devices for equity price changes and breaking news stories? Let us know here.
 
Existing alertsView our existing alerts
Find More Stocks
Find More Stocks
Use our equities screener to discover other potential opportunities.
 
Equities ScreenerGo to the Equities Screener

Profile data is unavailable for this security.

About the company

Odonate, Inc., formerly Odonate Therapeutics, Inc., is a pharmaceutical company. The Company is focused on the development of tesetaxel, an investigational, orally administered chemotherapy agent that belongs to a class of drugs known as taxanes, which are used in the treatment of cancer. The Company is no longer in development of tesetax.

  • Revenue in USD (TTM)0.00
  • Net income in USD-102.07m
  • Incorporated2013
  • Employees137.00
  • Location
    Odonate Inc4747 Executive Drive Ste 210SAN DIEGO 92121United StatesUSA
  • Phone+1 (858) 200-3830
  • Fax+1 (302) 655-5049
  • Websitehttps://www.odonate.com/
More ▼

Peer analysis

Key Information
CompanyRevenue (TTM)Net income (TTM)Market capEmployeesPrice/earnings (TTM)Price/book value (MRQ)Price/cash flow (TTM)Price/sales (TTM)EPS (excl. extraordinary items, TTM)EPS (incl. extraordinary items, TTM)Revenue per share (TTM)Book value per share (MRQ)Asset turnover (TTM)Inventory turnover (TTM)Receivables turnover (TTM)Revenues per employee (TTM)Return on avg assets (TTM)Return on avg assets (5 yr avg)Return on investment (TTM)Return on investment (5 yr avg)Gross margin (TTM)Gross margin
(5 yr avg)
Net profit margin (TTM)Net Profit margin
(5 yr avg)
Quick ratio (MRQ)Interest coverage (TTM)Total debt to capital (MRQ)Payout ratio
(5 yr avg)
Revenue
(YOY change %)
Revenue
(5 yr growth rate)
Net income
(YOY change %)
Net income
(5 yr growth rate)
Capital expenditure
(5 yr growth rate)
Dividend
(5 yr growth rate)
Lexaria Bioscience Corp404.72k-5.44m37.81m5.00--5.02--93.43-0.6851-0.68510.04930.52640.0722--1.6480,944.00-97.62-95.67-94.18-96.5895.6676.98-1,351.64-1,612.76---175.330.00---11.43-12.198.31------
Fortress Biotech Inc85.11m-62.86m39.50m186.00--1.48--0.464-6.65-6.657.961.190.39762.274.55457,602.20-64.47-52.50-107.85-99.4668.2563.17-162.17-236.941.21-10.181.07--11.5825.7527.42---9.37--
Qilian International Holding Group Ltd46.47m-7.78m40.25m298.00--0.9407--0.8662-1.09-1.096.505.980.80276.4533.30155,944.60-14.032.71-16.843.863.7711.66-17.482.724.43-0.48120.010726.11-28.35-1.60-822.64--12.86--
Ocuphire Pharma Inc19.01m-11.30m40.96m14.00--0.8606--2.15-0.4867-0.48670.83661.840.391--4.521,357,929.00-23.24-58.31-25.89-65.94-----59.44-137.92---7.800.00---52.20---155.83------
Eyenovia Inc8.78k-32.44m42.23m57.00--20.03--4,809.50-0.7448-0.74480.00020.03840.0003--0.008154.04-116.94-80.31-190.14-117.700.00---369,519.70-680.950.6645-16.030.8914------2.68--152.20--
Incannex Healthcare Inc-100.00bn-100.00bn43.49m----3.08----------0.8907-----------54.94---59.47-------1,033.07----0.00--61.923.38-24.35--54.12--
United-Guardian, Inc.11.57m2.75m44.03m25.0016.013.9415.423.810.59870.59872.522.430.9263.176.40462,790.8022.0229.8425.9434.3948.6455.3123.7828.795.99--0.0097.37-14.28-4.140.4616-9.9217.19-19.73
Bright Green Corp0.00-11.46m49.82m5.00--4.48-----0.0631-0.06310.000.05840.00----0.00-56.05---84.87-------------18,125.840.0289------52.54------
Odonate Inc0.00-102.07m50.02m137.00--1,844.41-----13.59-13.590.009.270.00----0.00-66.98-58.36-83.00-65.14------------0.00-------12.99------
Turnstone Biologics Corp0.00-74.92m52.04m82.00--0.6504-----3.53-3.530.003.460.00----0.00-80.25---94.45--------------0.00---73.66---78.05------
Rockwell Medical Inc86.62m-8.42m53.60m237.00--2.53--0.6188-0.3584-0.35843.330.69841.9013.2810.12365,485.20-18.47-46.29-27.53-65.3810.594.66-9.72-36.511.38-3.540.331--14.845.6954.82--76.21--
CEL-SCI Corp0.00-29.95m59.58m43.00--4.16-----0.6304-0.63040.000.26450.00-------87.78-70.19-103.56-78.31-------15,434.151.18-39.260.4319------13.99--223.59--
Gritstone bio Inc15.65m-144.89m62.04m231.00--4.01--3.97-1.57-1.570.170.14230.0901--40.5367,727.27-83.47-48.08-97.70-55.18-----926.13-573.71---554.880.7428---18.0568.96-15.71---4.19--
Immix Biopharma Inc0.00-18.21m64.72m14.00--2.32-----0.9263-0.92630.001.060.00----0.00-77.50---90.46--------------0.00-------87.44------
Data as of Jun 26 2024. Currency figures normalised to Odonate Inc's reporting currency: US Dollar USD

Institutional shareholders

0.03%Per cent of shares held by top holders
HolderShares% Held
DWS Investments (UK) Ltd.as of 06 Jun 20241.000.03%
Fidelity Management & Research Co. LLCas of 31 Mar 20240.000.00%
BBVA Asset Management SA SGIICas of 31 Dec 20230.000.00%
Data from 31 Mar 2024 - 31 Mar 2024Source: FactSet Research Systems Inc.
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.